Submission Details
| 510(k) Number | K182074 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 2018 |
| Decision Date | March 21, 2019 |
| Days to Decision | 232 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K182074 is an FDA 510(k) clearance for the Mineral Collagen Composite Bioactive Moldable, a Filler, Bone Void, Calcium Compound (Class II — Special Controls, product code MQV), submitted by Collagen Matrix, Inc. (Oakland, US). The FDA issued a Cleared decision on March 21, 2019, 232 days after receiving the submission on August 1, 2018. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3045.
| 510(k) Number | K182074 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 2018 |
| Decision Date | March 21, 2019 |
| Days to Decision | 232 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MQV — Filler, Bone Void, Calcium Compound |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3045 |